Ultragenyx Pharmaceutical (RARE) Assets (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Ultragenyx Pharmaceutical | 2.29 Bn | 1.89 Bn | 106.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.40% |
| Dec 31, 2025 | 28.69% |
| Sep 30, 2025 | -8.87% |
| Jun 30, 2025 | -0.43% |
| Mar 31, 2025 | -12.71% |
| Dec 31, 2024 | -2.30% |
| Sep 30, 2024 | -4.95% |
| Jun 30, 2024 | 23.82% |
| Mar 31, 2024 | -12.34% |
| Dec 31, 2023 | 20.42% |
| Sep 30, 2023 | -5.58% |
| Jun 30, 2023 | -5.21% |
| Mar 31, 2023 | -10.49% |
| Dec 31, 2022 | -4.51% |
| Sep 30, 2022 | 22.55% |
| Jun 30, 2022 | -4.58% |
| Mar 31, 2022 | -9.09% |
| Dec 31, 2021 | 2.53% |
| Sep 30, 2021 | -1.83% |
| Jun 30, 2021 | -5.34% |
| Mar 31, 2021 | -9.20% |
| Dec 31, 2020 | 38.72% |
| Mar 31, 2020 | 8.60% |
| Dec 31, 2019 | 29.04% |
| Sep 30, 2019 | -8.24% |
| Jun 30, 2019 | -4.85% |
| Mar 31, 2019 | 40.05% |
| Dec 31, 2018 | -5.96% |
| Sep 30, 2018 | -5.07% |
| Jun 30, 2018 | -1.39% |
| Mar 31, 2018 | 66.55% |
| Dec 31, 2017 | 12.80% |
| Sep 30, 2017 | -12.56% |
| Jun 30, 2017 | -8.85% |
| Mar 31, 2017 | 0.96% |
| Dec 31, 2016 | 4.94% |
| Sep 30, 2016 | 6.89% |
| Jun 30, 2016 | -8.06% |
| Mar 31, 2016 | -6.32% |
| Dec 31, 2015 | -7.07% |
| Sep 30, 2015 | 75.55% |
| Jun 30, 2015 | -3.61% |
| Mar 31, 2015 | 79.75% |
| Dec 31, 2014 | -6.15% |
| Sep 30, 2014 | 29.74% |
| Jun 30, 2014 | -5.86% |
| Mar 31, 2014 | 189.54% |